Medroxyprogesterone Acetate anticorps

N° du produit ABIN487732

Détail du produit anti-Medroxyprogesterone Acetate anticorps

Antigène: Medroxyprogesterone Acetate

Reactivité: Veuillez nous consulter SVP

Hôte: Mouton

Clonalité: Polyclonal

Conjugué: Cet anticorp Medroxyprogesterone Acetate est non-conjugé

Application: Enzyme Immunoassay (EIA)

Purification: Ig Fraction

Immunogène: Medroxyprogesterone acetate (3)-BTG

Isotype: IgG

Information d'application

Indications d'application: ELISA: 0.1 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 9.70mg/mL (U.V. abs at 280nm)

Buffer: 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: -20 °C

Détails sur Medroxyprogesterone Acetate

Antigène: Medroxyprogesterone Acetate

Abstract: Medroxyprogesterone Acetate Produits

Classe de substances: Chemical

Sujet: MPA (also known as depo provera) is a highly potent progestational steroid that has been used worldwide as a contraceptive. There has been a concern about the possibility of an increased risk of breast cancer associated with its use. On the other hand, MPA when employed at high doses (>0.5 - 1.0g / day i.m.) can produce objective remission with improved survival in about 30?% of postmenopausal women with advanced breast cancer resistant to cytotoxic drugs and endocrine therapies. Early results suggest that the response rate can be increased in patients with estrogen and / or progesterone positive receptors.Synonyms: MPA, Medroxy Progesterone Acetate, depo provera